Editorial
To each his own: a personalized vaccine for metastatic melanoma
Abstract
By combining bioinformatics and sequencing analysis, it is now possible to identify the private tumor neoantigens derived from an individual patient’s tumor, and use these antigens to manufacture personalized vaccines.
